Proposed Data Collection Submitted for Public Comment and Recommendations, 21876-21878 [2016-08443]
Download as PDF
<![CDATA[
21876
Federal Register / Vol. 81, No. 71 / Wednesday, April 13, 2016 / Notices
EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents
Form name
Total ......................................................................................................................................
Exhibit 2 shows the estimated
annualized cost burden associated with
the participants’ time to take part in this
325
Hours per
response
Total burden
hours
NA
295
research. The total cost burden is
estimated to be $27,270.45.
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN
Total burden
hours
Interviewee type
Average
hourly
age rate *
Total cost
burden
Frontline clinicians .......................................................................................................................
Medical group administrators ...............................................................................................
90
205
$103.54 a
87.57 b
$9,318.60
17,951.85
Total ......................................................................................................................................
295
NA
27,270.45
a Based
on the average hourly wage for one physician (29–1060; $103.54).
on the average hourly wage for one Chief Executive (11–1011; $87.57).
* National Industry-Specific Occupational Employment and Wage Estimates, May 2014, from the Bureau of Labor Statistics (available at https://
www.bls.gov/oes/current/naics4_621100.htm [for Offices of Physicians, NAICS 622100]).
b Based
Request for Comments
asabaliauskas on DSK3SPTVN1PROD with NOTICES
In accordance with the Paperwork
Reduction Act, comments on AHRQ’s
information collection are requested
with regard to any of the following: (a)
Whether the proposed collection of
information is necessary for the proper
performance of AHRQ health care
research and health care information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Sharon B. Arnold,
Acting Director.
[FR Doc. 2016–08403 Filed 4–12–16; 8:45 am]
BILLING CODE 4160–90–P
VerDate Sep<11>2014
17:41 Apr 12, 2016
Jkt 238001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Toxic Substances and
Disease Registry
[60Day–16–0041; Docket No. ATSDR–2016–
0005]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Agency for Toxic Substances
and Disease Registry (ATSDR),
Department of Health and Human
Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Agency for Toxic
Substances and Disease Registry
(ATSDR), as part of its continuing
efforts to reduce public burden and
maximize the utility of government
information, invites the general public
and other Federal agencies to take this
opportunity to comment on proposed
and/or continuing information
collections, as required by the
Paperwork Reduction Act of 1995. This
notice invites comment on the
‘‘National Amyotrophic Lateral
Sclerosis (ALS) Registry.’’ The National
ALS Registry collects information from
persons with ALS to better describe the
prevalence and potential risk factors for
ALS.
DATES: Written comments must be
received on or before June 13, 2016.
ADDRESSES: You may submit comments,
identified by Docket No. ATSDR–2016–
0005 by any of the following methods:
SUMMARY:
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
• Federal eRulemaking Portal:
Regulation.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations, gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
Please note: All public comment should be
submitted through the Federal eRulemaking
portal (Regulations.gov) or by U.S. mail to the
address listed above.
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact the Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\13APN1.SGM
13APN1
21877
Federal Register / Vol. 81, No. 71 / Wednesday, April 13, 2016 / Notices
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
Proposed Project
The National Amyotrophic Lateral
Sclerosis (ALS) Registry (OMB Control
No. 0923–0041, Expiration Date 09/30/
2016)—Revision—Agency for Toxic
Substances and Disease Registry
(ATSDR).
progression survey is repeated at the
yearly anniversary and at 6 months. For
burden estimation, the number of
disease progression survey responses
per year has been rounded up to 3
times.
A biorepository component is being
added to increase the value of the
National ALS Registry to researchers. As
part of registration the participant can
request additional information about the
biorepository and provide additional
contact information. A geographically
representative sample will be selected to
provide specimens. There are two types
of specimen collections, in-home and
postmortem. The in-home collection
includes blood, urine, hair and nails.
The postmortem collection includes the
brain, spinal cord, cerebral spinal fluid
(CSF), bone, muscle, and skin.
In addition to fulfilling the two-part
Congressional mandate, the Registry is
designed to be a tool for ALS
researchers. Now that the Registry has
matured, ATSDR will make data and
specimens available to approved
researchers and has added a respondent
type. Researchers can request access to
specimens, data, or both collected by
the National ALS Registry for their
research projects. ATSDR will review
applications for scientific validity and
human subjects’ protection and make
data/specimens available to approved
researchers.
ATSDR is collaborating with ALS
service organizations to conduct
outreach activities through their local
chapters and districts as well as on a
national level. They provide ATSDR
with information on their outreach
efforts in support of the Registry on a
monthly basis.
There are no costs to the respondents
other than their time. The total number
of burden hours requested is 1,986
hours.
Background and Brief Description
On October 10, 2008, President Bush
signed S. 1382: ALS Registry Act which
amended the Public Health Service Act
to provide for the establishment of an
Amyotrophic Lateral Sclerosis (ALS)
Registry. The activities described are
part of the ongoing effort to maintain the
National ALS Registry.
First approved in 2010 for selfregistration, the primary goal of the
surveillance system/registry remains to
obtain reliable information on the
incidence and prevalence of ALS and to
better describe the demographic
characteristics (age, race, sex, and
geographic location) of persons with
ALS (PALS). Those interested in
participating in the National ALS
Registry must answer a series of
validation questions and if determined
to be eligible they can register.
The secondary goal of the surveillance
system/registry is to collect additional
information on potential risk factors for
ALS, including, but not limited to,
family history of ALS, smoking history,
military service, residential history, lifetime occupational exposure, home
pesticide use, hobbies, hormonal and
reproductive history (women only),
caffeine use, trauma, health insurance,
open-ended supplemental questions,
and clinical signs and symptoms. After
registration, participants complete as
many as 16 voluntary survey modules,
each taking five minutes (maximum 80
minutes). In addition, in Year 1, a
disease progression survey for new
registrants is completed at 0, 3, and 6
months. In Years 2 and 3, the disease
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
Form name
Person with ALS .................
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Type of respondent
ALS Case Validation Questions .....................
ALS Case Registration Form .........................
Voluntary Survey Modules .............................
Disease Progression Survey ..........................
ALS Biorepository Specimen Processing
Form.
ALS Registry Research Application Application Form.
Annual Update Form ......................................
Chapter/District Outreach Reporting Form .....
National Office Outreach Reporting Form ......
1,670
1,500
750
750
325
1
1
1
3
1
2/60
10/60
80/60
5/60
1
56
250
1,000
188
325
36
1
30/60
18
24
135
2
1
12
12
15/60
5/60
20/60
6
135
8
.........................................................................
........................
........................
........................
1,986
Researchers .......................
ALS Service Organization ..
Total .............................
VerDate Sep<11>2014
17:41 Apr 12, 2016
Jkt 238001
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
E:\FR\FM\13APN1.SGM
13APN1
21878
Federal Register / Vol. 81, No. 71 / Wednesday, April 13, 2016 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–08443 Filed 4–12–16; 8:45 am]
BILLING CODE 4163–70–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH): Notice of Charter Reestablishment
Pursuant to Executive Order 13708
and the Federal Advisory Committee
Act (Pub. L. 92–463) of October 6, 1972,
the Director, Centers for Disease Control
and Prevention (CDC) announces the reestablishment of the Advisory Board on
Radiation and Worker Health,
Department of Health and Human
Services, extending through September
30, 2017.
Contact Person for More Information:
Theodore Katz, Designated Federal
Officer, NIOSH, CDC, 1600 Clifton Road
NE., MS E–20, Atlanta, Georgia 30329–
4027, telephone (513) 533–6800, toll
free: 1–800–CDC–INFO, email:
dcas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2016–08517 Filed 4–12–16; 8:45 am]
BILLING CODE 4163–18–P
asabaliauskas on DSK3SPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement
(FOA), PAR 15–353, Centers for
Agricultural Safety and Health.
Times and Dates:
8:30 a.m.–8:30 p.m., EDT, May 9, 2016
(Closed)
8:30 a.m.–8:30 p.m., EDT, May 10, 2016
(Closed)
8:30 a.m.–8:30 p.m., EDT, May 11, 2016
(Closed)
8:30 a.m.–8:30 p.m., EDT, May 12, 2016
(Closed)
8:30 a.m.–8:30 p.m., EDT, May 13, 2016
(Closed)
Place: Crowne Plaza Atlanta
Perimeter at Ravinia, 4355 Ashford
Dunwoody Road, Atlanta, Georgia
30346–1521 Telephone: (770) 395–7700
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Centers for Agricultural Safety and
Health’’, PAR 15–353.
Contact Person for More Information:
Donald Blackman, Ph.D., Scientific
Review Officer, CDC/NIOSH, 2400
Century Center Parkway NE., 4th Floor,
Room 4204, Mailstop E–74, Atlanta,
Georgia 30345, Telephone: (404) 498–
6185, DYB7@CDC.GOV.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Centers for Disease Control and
Prevention
[FR Doc. 2016–08518 Filed 4–12–16; 8:45 am]
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
BILLING CODE 4163–18–P
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
VerDate Sep<11>2014
17:41 Apr 12, 2016
Jkt 238001
PO 00000
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day-16–16ZX; Docket No. CDC–2016–
0037]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on the Environmental Public
Health Tracking Network, an
information system which collects data
from (1) other CDC programs such as the
National Center for Health Statistics, (2)
other federal agencies such as the
Environmental Protection Agency, (3)
publically accessible systems such as
the Census Bureau, and (4) funded and
unfunded state and local health
departments (SLHD).
DATES: Written comments must be
received on or before June 13, 2016.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2016–
0037 by any of the following methods:
• Federal eRulemaking Portal:
Regulation.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
SUMMARY:
Please note: All public comment should be
submitted through the Federal eRulemaking
portal (Regulations.gov) or by U.S. mail to the
address listed above.
To
request more information on the
proposed project or to obtain a copy of
FOR FURTHER INFORMATION CONTACT:
Frm 00043
Fmt 4703
Sfmt 4703
E:\FR\FM\13APN1.SGM
13APN1
]]>Agencies
[Federal Register Volume 81, Number 71 (Wednesday, April 13, 2016)]
[Notices]
[Pages 21876-21878]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-08443]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Toxic Substances and Disease Registry
[60Day-16-0041; Docket No. ATSDR-2016-0005]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Agency for Toxic Substances and Disease Registry (ATSDR),
Department of Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Agency for Toxic Substances and Disease Registry (ATSDR),
as part of its continuing efforts to reduce public burden and maximize
the utility of government information, invites the general public and
other Federal agencies to take this opportunity to comment on proposed
and/or continuing information collections, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on the ``National
Amyotrophic Lateral Sclerosis (ALS) Registry.'' The National ALS
Registry collects information from persons with ALS to better describe
the prevalence and potential risk factors for ALS.
DATES: Written comments must be received on or before June 13, 2016.
ADDRESSES: You may submit comments, identified by Docket No. ATSDR-
2016-0005 by any of the following methods:
Federal eRulemaking Portal: Regulation.gov. Follow the
instructions for submitting comments.
Mail: Leroy A. Richardson, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE., MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to Regulations, gov, including any personal information
provided. For access to the docket to read background documents or
comments received, go to Regulations.gov.
Please note: All public comment should be submitted through the
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact the Information Collection Review Office,
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of
[[Page 21877]]
information, including each new proposed collection, each proposed
extension of existing collection of information, and each reinstatement
of previously approved information collection before submitting the
collection to OMB for approval. To comply with this requirement, we are
publishing this notice of a proposed data collection as described
below.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; (d) ways to
minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services
to provide information. Burden means the total time, effort, or
financial resources expended by persons to generate, maintain, retain,
disclose or provide information to or for a Federal agency. This
includes the time needed to review instructions; to develop, acquire,
install and utilize technology and systems for the purpose of
collecting, validating and verifying information, processing and
maintaining information, and disclosing and providing information; to
train personnel and to be able to respond to a collection of
information, to search data sources, to complete and review the
collection of information; and to transmit or otherwise disclose the
information.
Proposed Project
The National Amyotrophic Lateral Sclerosis (ALS) Registry (OMB
Control No. 0923-0041, Expiration Date 09/30/2016)--Revision--Agency
for Toxic Substances and Disease Registry (ATSDR).
Background and Brief Description
On October 10, 2008, President Bush signed S. 1382: ALS Registry
Act which amended the Public Health Service Act to provide for the
establishment of an Amyotrophic Lateral Sclerosis (ALS) Registry. The
activities described are part of the ongoing effort to maintain the
National ALS Registry.
First approved in 2010 for self-registration, the primary goal of
the surveillance system/registry remains to obtain reliable information
on the incidence and prevalence of ALS and to better describe the
demographic characteristics (age, race, sex, and geographic location)
of persons with ALS (PALS). Those interested in participating in the
National ALS Registry must answer a series of validation questions and
if determined to be eligible they can register.
The secondary goal of the surveillance system/registry is to
collect additional information on potential risk factors for ALS,
including, but not limited to, family history of ALS, smoking history,
military service, residential history, life-time occupational exposure,
home pesticide use, hobbies, hormonal and reproductive history (women
only), caffeine use, trauma, health insurance, open-ended supplemental
questions, and clinical signs and symptoms. After registration,
participants complete as many as 16 voluntary survey modules, each
taking five minutes (maximum 80 minutes). In addition, in Year 1, a
disease progression survey for new registrants is completed at 0, 3,
and 6 months. In Years 2 and 3, the disease progression survey is
repeated at the yearly anniversary and at 6 months. For burden
estimation, the number of disease progression survey responses per year
has been rounded up to 3 times.
A biorepository component is being added to increase the value of
the National ALS Registry to researchers. As part of registration the
participant can request additional information about the biorepository
and provide additional contact information. A geographically
representative sample will be selected to provide specimens. There are
two types of specimen collections, in-home and postmortem. The in-home
collection includes blood, urine, hair and nails. The postmortem
collection includes the brain, spinal cord, cerebral spinal fluid
(CSF), bone, muscle, and skin.
In addition to fulfilling the two-part Congressional mandate, the
Registry is designed to be a tool for ALS researchers. Now that the
Registry has matured, ATSDR will make data and specimens available to
approved researchers and has added a respondent type. Researchers can
request access to specimens, data, or both collected by the National
ALS Registry for their research projects. ATSDR will review
applications for scientific validity and human subjects' protection and
make data/specimens available to approved researchers.
ATSDR is collaborating with ALS service organizations to conduct
outreach activities through their local chapters and districts as well
as on a national level. They provide ATSDR with information on their
outreach efforts in support of the Registry on a monthly basis.
There are no costs to the respondents other than their time. The
total number of burden hours requested is 1,986 hours.
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondent Form name respondents responses per response (in (in hours)
respondent hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Person with ALS..................................... ALS Case Validation Questions..... 1,670 1 2/60 56
ALS Case Registration Form........ 1,500 1 10/60 250
Voluntary Survey Modules.......... 750 1 80/60 1,000
Disease Progression Survey........ 750 3 5/60 188
ALS Biorepository Specimen 325 1 1 325
Processing Form.
Researchers......................................... ALS Registry Research Application 36 1 30/60 18
Application Form.
Annual Update Form................ 24 1 15/60 6
ALS Service Organization............................ Chapter/District Outreach 135 12 5/60 135
Reporting Form.
National Office Outreach Reporting 2 12 20/60 8
Form.
rrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrr
Total........................................... .................................. .............. .............. .............. 1,986
--------------------------------------------------------------------------------------------------------------------------------------------------------
[[Page 21878]]
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-08443 Filed 4-12-16; 8:45 am]
BILLING CODE 4163-70-P
